12 Einträge gefunden

1. Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma

   1. Mai, Elias K
   2. Huhn, Stefanie
   3. Miah, Kaya
   4. Poos, Alexandra M
   5. Scheid, Christof
   6. Weisel, Katja C
   7. Bertsch, Uta

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial

   1. Goldschmidt, Hartmut
   2. Mai, Elias K
   3. Bertsch, Uta
   4. Fenk, Roland
   5. Nievergall, Eva
   6. Tichy, Diana
   7. Besemer, Britta

   2022 - Forschungsinformationssystem des UKE
3. MCT1 is a Predictive Marker for Lenalidomide Maintenance Therapy in Multiple Myeloma

   1. Stroh, Jacob
   2. Seckinger, Anja
   3. Heider, Michael
   4. Rudelius, Martina
   5. Eichner, Ruth
   6. Schick, Markus
   7. Slawska, Jolanta

   2022 - Forschungsinformationssystem des UKE
4. Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial

   1. Salwender, Hans
   2. Elmaagacli, Ahmet
   3. Merz, Maximilian
   4. Miah, Kaya
   5. Benner, Axel
   6. Haenel, Mathias
   7. Jehn, Christian

   2021 - Forschungsinformationssystem des UKE
5. Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma

   1. Baertsch, Marc-Andrea
   2. Mai, Elias K
   3. Hielscher, Thomas
   4. Bertsch, Uta
   5. Salwender, Hans J
   6. Munder, Markus
   7. Fuhrmann, Stephan

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
6. Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial

   1. Klein, Eva-Maria
   2. Tichy, Diana
   3. Salwender, Hans J
   4. Mai, Elias K
   5. Duerig, Jan
   6. Weisel, Katja C
   7. Benner, Axel

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
7. Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age

   1. Mai, Elias K
   2. Miah, Kaya
   3. Bertsch, Uta
   4. Dürig, Jan
   5. Scheid, Christof
   6. Weisel, Katja C
   7. Kunz, Christina

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
8. Selective elimination of immunosuppressive T cells in patients with multiple myeloma

   1. Awwad, Mohamed H S
   2. Mahmoud, Abdelrahman
   3. Bruns, Heiko
   4. Echchannaoui, Hakim
   5. Kriegsmann, Katharina
   6. Lutz, Raphael
   7. Raab, Marc S

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
9. Comparison of NGS and MFC Methods: Key Metrics in Multiple Myeloma MRD Assessment

   1. Kriegsmann, Katharina
   2. Hundemer, Michael
   3. Hofmeister-Mielke, Nicole
   4. Reichert, Philipp
   5. Manta, Calin-Petru
   6. Awwad, Mohamed H S
   7. Sauer, Sandra

   2020 - Forschungsinformationssystem des UKE
10. Response-adapted lenalidomide maintenance in newly diagnosed myeloma:results from the phase III GMMG-MM5 trial

    1. Goldschmidt, Hartmut
    2. Mai, Elias K
    3. Dürig, Jan
    4. Scheid, Christof
    5. Weisel, Katja C
    6. Kunz, Christina
    7. Bertsch, Uta

    2020 - Forschungsinformationssystem des UKE
11. Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myeloma

    1. Merz, Maximilian
    2. Hielscher, Thomas
    3. Mai, Elias Karl
    4. Seckinger, Anja
    5. Hose, Dirk
    6. Jauch, Anna
    7. Sauer, Sandra

    2019 - Forschungsinformationssystem des UKE - frei zugänglich
12. Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma

    1. Salwender, Hans
    2. Bertsch, Uta
    3. Weisel, Katja
    4. Duerig, Jan
    5. Kunz, Christina
    6. Benner, Axel
    7. Blau, Igor W

    2019 - Forschungsinformationssystem des UKE - frei zugänglich